Biotechnology Assets S.A. (BST) - Total Liabilities

Latest as of June 2025: €7.01 Million EUR ≈ $8.19 Million USD

Based on the latest financial reports, Biotechnology Assets S.A. (BST) has total liabilities worth €7.01 Million EUR (≈ $8.19 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BST cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Biotechnology Assets S.A. - Total Liabilities Trend (2010–2024)

This chart illustrates how Biotechnology Assets S.A.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BST total asset value.

Biotechnology Assets S.A. Competitors by Total Liabilities

The table below lists competitors of Biotechnology Assets S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Malpac Holdings Bhd KLSE:4936	Malaysia	RM8.95 Million
Powerhouse Ventures Ltd AU:PVL	Australia	AU$2.05 Million
Tomypak Holdings Bhd KLSE:7285	Malaysia	RM144.20 Million
SolTech Energy Sweden AB ST:SOLT	Sweden	Skr1.35 Billion
Anebulo Pharmaceuticals Inc NASDAQ:ANEB	USA	$1.49 Million
DeepMarkit Corp V:MKT	Canada	CA$653.62K
Dolphin Entertainment Inc NASDAQ:DLPN	USA	$48.64 Million
M Cash Integrasi Tbk PT JK:MCAS	Indonesia	Rp810.08 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down Biotechnology Assets S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BST equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotechnology Assets S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotechnology Assets S.A. (2010–2024)

The table below shows the annual total liabilities of Biotechnology Assets S.A. from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	€8.17 Million ≈ $9.56 Million	-18.87%
2023-12-31	€10.08 Million ≈ $11.78 Million	-30.99%
2022-12-31	€14.60 Million ≈ $17.07 Million	-6.02%
2021-12-31	€15.54 Million ≈ $18.16 Million	-5.08%
2020-12-31	€16.37 Million ≈ $19.14 Million	-80.77%
2019-12-31	€85.11 Million ≈ $99.50 Million	+46.62%
2018-12-31	€58.04 Million ≈ $67.86 Million	+507.37%
2017-12-31	€9.56 Million ≈ $11.17 Million	+19.22%
2016-12-31	€8.02 Million ≈ $9.37 Million	+10.90%
2015-12-31	€7.23 Million ≈ $8.45 Million	+3.17%
2014-12-31	€7.01 Million ≈ $8.19 Million	+40.00%
2013-12-31	€5.00 Million ≈ $5.85 Million	+5.20%
2012-12-31	€4.76 Million ≈ $5.56 Million	+1.37%
2011-12-31	€4.69 Million ≈ $5.49 Million	+65.30%
2010-12-31	€2.84 Million ≈ $3.32 Million	--

About Biotechnology Assets S.A.

MC:BST Spain Biotechnology

Market Cap

$18.02 Million

€15.41 Million EUR

Market Cap Rank

#26374 Global

#200 in Spain

Share Price

€0.22

Change (1 day)

-0.46%

52-Week Range

€0.18 - €0.41

All Time High

€3.31